Sleep quality (Pittsburgh Sleep Quality Index), anxiety (7-item Generalized Anxiety Disorder Scale), depression (9-item Patient Health Questionnaire), and metabolic indicators (glycated hemoglobin [HbA1c], homeostasis model assessment of insulin resistance, high-sensitivity C-reactive protein) were measured. The gene discussed is INS; the disease is depressive disorder.